Skip to main content

Table 2 Components of human whole blood and PRPs

From: Advantages of pure platelet-rich plasma compared with leukocyte- and platelet-rich plasma in promoting repair of bone defects

 

Platelet concentration (109/L)

Leukocyte concentration (109/L)

PDGF-AB concentration (ng/mL)

TGF-β1  concentration (ng/mL)

VEGF concentration (pg/mL)

IL-1β concentration (pg/mL)

TNF-α concentration (pg/mL)

WB

228.30 ± 50.50

6.18 ± 1.57

8.87 ± 4.67

23.83 ± 12.07

35.92 ± 8.51

11.68 ± 5.90

9.31 ± 5.05

L-PRP

1436.70 ± 257.97

34.58 ± 8.48

42.54 ± 12.65

122.22 ± 43.42

157.89 ± 33.64

93.33 ± 69.88

54.67 ± 27.10

P-PRP

1461.80 ± 189.14

0.18 ± 0.18

43.71 ± 14.39

126.95 ± 35.96

151.82 ± 29.29

3.83 ± 2.61

2.20 ± 0.78

Comparison, P value

 ANOVA

<0.001*

<0.001*

<0.001*

<0.001*

<0.001*

<0.001*

<0.001*

 WB vs. L-PRP

<0.001*

<0.001*

<0.001*

<0.001*

<0.001*

<0.001*

<0.001*

 WB vs. P-PRP

<0.001*

0.036*

<0.001*

<0.001*

<0.001*

>0.999

0.979

 L-PRP vs. P-PRP

>0.999

<0.001*

>0.999

>0.999

>0.999

<0.001*

<0.001*

  1. The asterisks indicate the significant differences between groups on ANOVA and with use of the Bonferroni post hoc test for multiple comparisons (P < 0.05)
  2. WB whole blood